Cargando…
When to change treatment of acute invasive aspergillosis: an expert viewpoint
Invasive aspergillosis (IA) is an acute infection affecting patients who are immunocompromised, as a result of receiving chemotherapy for malignancy, or immunosuppressant agents for transplantation or autoimmune disease. Whilst criteria exist to define the probability of infection for clinical trial...
Autores principales: | Slavin, Monica A, Chen, Yee-Chun, Cordonnier, Catherine, Cornely, Oliver A, Cuenca-Estrella, Manuel, Donnelly, J Peter, Groll, Andreas H, Lortholary, Olivier, Marty, Francisco M, Nucci, Marcio, Rex, John H, Rijnders, Bart J A, Thompson, George R, Verweij, Paul E, White, P Lewis, Hargreaves, Ruth, Harvey, Emma, Maertens, Johan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730679/ https://www.ncbi.nlm.nih.gov/pubmed/34508633 http://dx.doi.org/10.1093/jac/dkab317 |
Ejemplares similares
-
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
por: Verweij, Paul E., et al.
Publicado: (2020) -
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis – Authors' reply
por: Koehler, Philipp, et al.
Publicado: (2021) -
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
por: Verweij, Paul E., et al.
Publicado: (2021) -
P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study
por: Huygens, Sammy, et al.
Publicado: (2022) -
Influenza Coinfection: Be(a)ware of Invasive Aspergillosis
por: Verweij, Paul E, et al.
Publicado: (2020)